|Articles|January 15, 2002

BioPharm International

  • BioPharm International-01-01-2002
  • Volume 15
  • Issue 1

Information Age Audits

by Joseph F. Noferi, Daniel E. Worden, and Edward R. Arling Understanding the reach of 21 CFR Part 11 is the first step to assessing its impact. To protect your company, you need integrated quality audit solutions to evaluate the underlying validation of your electronic data.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

about 24 years ago

Outsourcing Outlook: E-Sourcing, Internet Facilitates Flexible Collaboration

about 24 years ago

Inside Washington: Biotechnology in the Limelight, the Year Ahead

about 24 years ago

Your Vested Interests: The War of the West

about 24 years ago

Statistics for Laboratory Method Comparison Studies

about 24 years ago

From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continues

about 24 years ago

Systematic Troubleshooting for LC/MS/MS: Part 2, Large-Scale LC/MS/MS and Automation

about 24 years ago

Liposomes (a Review): Part Two, Drug Delivery Systems

about 25 years ago

Considerations During Development of a Protein A-Based Antibody Purification Process

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!